Selected research
Industry Growth & Trends
Global Ioversol Injection Industry Growth and Trends Forecast to 2032
Market perspective
According to APO Research, the global Ioversol Injection market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Ioversol Injection is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Ioversol Injection is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Ioversol Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global companies in the Ioversol Injection market include GUERBET, Zhejiang Starry Pharmaceutical, Hengrui Pharmaceuticals, Bayer HealthCare Pharmaceuticals, Neptunus Bio-pharmaceutical, Liebel-Flarsheim Company LLC and Bracco Imaging S.p.A., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Ioversol Injection market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Ioversol Injection market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Ioversol Injection market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Ioversol Injection.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading companies in the global Ioversol Injection market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Ioversol Injection Market by Company
GUERBET
Zhejiang Starry Pharmaceutical
Hengrui Pharmaceuticals
Bayer HealthCare Pharmaceuticals
Neptunus Bio-pharmaceutical
Liebel-Flarsheim Company LLC
Bracco Imaging S.p.A.
Ioversol Injection Segment by Type
50mL
75mL
100mL
125mL
Ioversol Injection Segment by Application
Hospital
Clinic
Others
Ioversol Injection Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Ioversol Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Ioversol Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Ioversol Injection.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Ioversol Injection companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- 50mL
- 75mL
- 100mL
- 125mL
Applications
- Hospital
- Clinic
- Others
Companies covered
- GUERBET
- Zhejiang Starry Pharmaceutical
- Hengrui Pharmaceuticals
- Bayer HealthCare Pharmaceuticals
- Neptunus Bio-pharmaceutical
- Liebel-Flarsheim Company LLC
- Bracco Imaging S.p.A.
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.3 Global Ioversol Injection Market Size Overview by Region 2021 VS 2025 VS 2032
- 1.4 Global Ioversol Injection Market Size by Region (2021-2032)
- 1.4.1 Global Ioversol Injection Market Size by Region (2021-2026)
- 1.4.2 Global Ioversol Injection Market Size by Region (2027-2032)
- 1.5 Key Regions Ioversol Injection Market Size (2021-2032)
- 1.5.1 North America Ioversol Injection Market Size Growth Rate (2021-2032)
- 1.5.2 Europe Ioversol Injection Market Size Growth Rate (2021-2032)
- 1.5.3 Asia-Pacific Ioversol Injection Market Size Growth Rate (2021-2032)
- 1.5.4 South America Ioversol Injection Market Size Growth Rate (2021-2032)
- 1.5.5 Middle East & Africa Ioversol Injection Market Size Growth Rate (2021-2032)
2 Ioversol Injection Market by Type
- 2.1 Type Introduction
- 2.1.1 50mL
- 2.1.2 75mL
- 2.1.3 100mL
- 2.1.4 125mL
- 2.2 Global Ioversol Injection Market Size by Type
- 2.2.1 Global Ioversol Injection Market Size Overview by Type (2021-2032)
- 2.2.2 Global Ioversol Injection Historic Market Size Review by Type (2021-2026)
- 2.2.3 Global Ioversol Injection Market Size Forecasted by Type (2027-2032)
- 2.3 Global Ioversol Injection Market Size by Regions
- 2.3.1 North America Ioversol Injection Market Size Breakdown by Type (2021-2026)
- 2.3.2 Europe Ioversol Injection Market Size Breakdown by Type (2021-2026)
- 2.3.3 Asia-Pacific Ioversol Injection Market Size Breakdown by Type (2021-2026)
- 2.3.4 South America Ioversol Injection Market Size Breakdown by Type (2021-2026)
- 2.3.5 Middle East and Africa Ioversol Injection Market Size Breakdown by Type (2021-2026)
3 Ioversol Injection Market by Application
- 3.1 Type Introduction
- 3.1.1 Hospital
- 3.1.2 Clinic
- 3.1.3 Others
- 3.2 Global Ioversol Injection Market Size by Application
- 3.2.1 Global Ioversol Injection Market Size Overview by Application (2021-2032)
- 3.2.2 Global Ioversol Injection Historic Market Size Review by Application (2021-2026)
- 3.2.3 Global Ioversol Injection Market Size Forecasted by Application (2027-2032)
- 3.3 Global Ioversol Injection Market Size by Regions
- 3.3.1 North America Ioversol Injection Market Size Breakdown by Application (2021-2026)
- 3.3.2 Europe Ioversol Injection Market Size Breakdown by Application (2021-2026)
- 3.3.3 Asia-Pacific Ioversol Injection Market Size Breakdown by Application (2021-2026)
- 3.3.4 South America Ioversol Injection Market Size Breakdown by Application (2021-2026)
- 3.3.5 Middle East and Africa Ioversol Injection Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
- 4.1 Ioversol Injection Industry Trends
- 4.2 Ioversol Injection Industry Drivers
- 4.3 Ioversol Injection Industry Opportunities and Challenges
- 4.4 Ioversol Injection Industry Restraints
5 Competitive Insights by Company
- 5.1 Global Top Players by Ioversol Injection Revenue (2021-2026)
- 5.2 Global Ioversol Injection Industry Company Ranking, 2024 VS 2025 VS 2026
- 5.3 Global Ioversol Injection Key Company Headquarters & Area Served
- 5.4 Global Ioversol Injection Company, Product Type & Application
- 5.5 Global Ioversol Injection Company Commercialization Time
- 5.6 Market Competitive Analysis
- 5.6.1 Global Ioversol Injection Market CR5 and HHI
- 5.6.2 Global Top 5 and 10 Ioversol Injection Players Market Share by Revenue in 2025
- 5.6.3 2025 Ioversol Injection Tier 1, Tier 2, and Tier 3
6 Company Profiles
- 6.1 GUERBET
- 6.1.1 GUERBET Company Information
- 6.1.2 GUERBET Business Overview
- 6.1.3 GUERBET Ioversol Injection Revenue, Global Share and Gross Margin (2021-2026)
- 6.1.4 GUERBET Ioversol Injection Product Portfolio
- 6.1.5 GUERBET Recent Developments
- 6.2 Zhejiang Starry Pharmaceutical
- 6.2.1 Zhejiang Starry Pharmaceutical Company Information
- 6.2.2 Zhejiang Starry Pharmaceutical Business Overview
- 6.2.3 Zhejiang Starry Pharmaceutical Ioversol Injection Revenue, Global Share and Gross Margin (2021-2026)
- 6.2.4 Zhejiang Starry Pharmaceutical Ioversol Injection Product Portfolio
- 6.2.5 Zhejiang Starry Pharmaceutical Recent Developments
- 6.3 Hengrui Pharmaceuticals
- 6.3.1 Hengrui Pharmaceuticals Company Information
- 6.3.2 Hengrui Pharmaceuticals Business Overview
- 6.3.3 Hengrui Pharmaceuticals Ioversol Injection Revenue, Global Share and Gross Margin (2021-2026)
- 6.3.4 Hengrui Pharmaceuticals Ioversol Injection Product Portfolio
- 6.3.5 Hengrui Pharmaceuticals Recent Developments
- 6.4 Bayer HealthCare Pharmaceuticals
- 6.4.1 Bayer HealthCare Pharmaceuticals Company Information
- 6.4.2 Bayer HealthCare Pharmaceuticals Business Overview
- 6.4.3 Bayer HealthCare Pharmaceuticals Ioversol Injection Revenue, Global Share and Gross Margin (2021-2026)
- 6.4.4 Bayer HealthCare Pharmaceuticals Ioversol Injection Product Portfolio
- 6.4.5 Bayer HealthCare Pharmaceuticals Recent Developments
- 6.5 Neptunus Bio-pharmaceutical
- 6.5.1 Neptunus Bio-pharmaceutical Company Information
- 6.5.2 Neptunus Bio-pharmaceutical Business Overview
- 6.5.3 Neptunus Bio-pharmaceutical Ioversol Injection Revenue, Global Share and Gross Margin (2021-2026)
- 6.5.4 Neptunus Bio-pharmaceutical Ioversol Injection Product Portfolio
- 6.5.5 Neptunus Bio-pharmaceutical Recent Developments
- 6.6 Liebel-Flarsheim Company LLC
- 6.6.1 Liebel-Flarsheim Company LLC Company Information
- 6.6.2 Liebel-Flarsheim Company LLC Business Overview
- 6.6.3 Liebel-Flarsheim Company LLC Ioversol Injection Revenue, Global Share and Gross Margin (2021-2026)
- 6.6.4 Liebel-Flarsheim Company LLC Ioversol Injection Product Portfolio
- 6.6.5 Liebel-Flarsheim Company LLC Recent Developments
- 6.7 Bracco Imaging S.p.A.
- 6.7.1 Bracco Imaging S.p.A. Company Information
- 6.7.2 Bracco Imaging S.p.A. Business Overview
- 6.7.3 Bracco Imaging S.p.A. Ioversol Injection Revenue, Global Share and Gross Margin (2021-2026)
- 6.7.4 Bracco Imaging S.p.A. Ioversol Injection Product Portfolio
- 6.7.5 Bracco Imaging S.p.A. Recent Developments
7 North America
- 7.1 North America Ioversol Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2 North America Ioversol Injection Market Size by Country (2021-2026)
- 7.3 North America Ioversol Injection Market Size Forecast by Country (2027-2032)
8 Europe
- 8.1 Europe Ioversol Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2 Europe Ioversol Injection Market Size by Country (2021-2026)
- 8.3 Europe Ioversol Injection Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Ioversol Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2 Asia-Pacific Ioversol Injection Market Size by Country (2021-2026)
- 9.3 Asia-Pacific Ioversol Injection Market Size Forecast by Country (2027-2032)
10 South America
- 10.1 South America Ioversol Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2 South America Ioversol Injection Market Size by Country (2021-2026)
- 10.3 South America Ioversol Injection Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Ioversol Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2 Middle East & Africa Ioversol Injection Market Size by Country (2021-2026)
- 11.3 Middle East & Africa Ioversol Injection Market Size Forecast by Country (2027-2032)
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst